ArticleOncotarget2016

Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.

Tingting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.